X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
D | 2024-03-26 | SWAV | Shockwave Medical, Inc. | Francis Laura | Dir | S - Sale+OE | $300.00 | -1,500 | 4,784 | -24% | -$450,000 | |||||
2024-03-26 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Pres, CCO | S - Sale | $287.67 | -4,000 | 56,818 | -7% | -$1,150,680 | ||||||
D | 2024-03-25 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $197.81 | -554 | 10,636 | -5% | -$109,587 | |||||
2024-03-26 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.18 | +5,096 | 15,215,145 | 0% | +$6,024 | ||||||
2024-03-22 | INSP | Inspire Medical Systems, Inc. | Rondoni John | CTO | S - Sale | $194.40 | -4,387 | 11,270 | -28% | -$852,849 | ||||||
2024-03-22 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $9.36 | -1,184 | 307,868 | 0% | -$11,082 | ||||||
2024-03-25 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief HR | S - Sale | $140.00 | -4,137 | 76,304 | -5% | -$579,180 | ||||||
2024-03-25 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.20 | +1,000,000 | 61,392,221 | +2% | +$200,000 | ||||||
2024-03-25 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.21 | +3,612 | 15,210,049 | 0% | +$4,368 | ||||||
D | 2024-03-22 | BVS | Bioventus Inc. | Singleton Mark Leonard | SVP, CFO | S - Sale+OE | $5.39 | -5,541 | 25,665 | -18% | -$29,853 | |||||
2024-03-20 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83,296 | -3% | -$44,511 | ||||||
2024-03-19 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.19 | +2,147 | 15,206,437 | 0% | +$2,555 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Aharon Gil | Dir | P - Purchase | $3.72 | +26,882 | 1,069,710 | +3% | +$100,001 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Salamon Steven A J | Dir | P - Purchase | $3.72 | +26,882 | 1,121,025 | +2% | +$100,001 | ||||||
2024-03-15 | BVS | Bioventus Inc. | D'Adamio Anthony | SVP, GC | S - Sale | $5.46 | -3,125 | 51,371 | -6% | -$17,063 | ||||||
2024-03-15 | BVS | Bioventus Inc. | Church Katrina J | SVP, Chief Compliance Officer | S - Sale | $5.46 | -1,217 | 14,067 | -8% | -$6,645 | ||||||
D | 2024-03-18 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $193.53 | -554 | 10,190 | -5% | -$107,216 | |||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $48.83 | -441 | 62,472 | -1% | -$21,534 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $48.83 | -1,024 | 102,149 | -1% | -$50,002 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Zadno Reza | Pres, CEO | S - Sale | $48.83 | -5,391 | 241,319 | -2% | -$263,243 | ||||||
2024-03-18 | PRCT | Procept Biorobotics Corp | Shiblaq Hisham | EVP, Chief Comm. Officer | S - Sale | $48.83 | -244 | 55,860 | 0% | -$11,915 | ||||||
2024-03-18 | NARI | Inari Medical, Inc. | Hoffman William | Dir | S - Sale | $41.13 | -40,000 | 1,003,296 | -4% | -$1,645,079 | ||||||
2024-03-18 | ATRC | Atricure, Inc. | Dahlquist Karl S. | GC | S - Sale | $32.16 | -1,885 | 50,954 | -4% | -$60,622 | ||||||
2024-03-15 | GMED | Globus Medical Inc | Norwalk Leslie V | Dir | S - Sale | $51.99 | -10,590 | 17,419 | -38% | -$550,574 | ||||||
2024-03-15 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corp Dev | S - Sale | $130.21 | -4,203 | 44,367 | -9% | -$547,259 | ||||||
2024-03-18 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $66.45 | -14,506 | 58,098 | -20% | -$963,930 | ||||||
2024-03-15 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -1,462 | 41,121 | -3% | -$29,240 | ||||||
2024-03-15 | FNA | Paragon 28, Inc. | Dacosta Albert | see remarks, 10% | P - Purchase | $9.12 | +28,000 | 11,007,446 | 0% | +$255,226 | ||||||
2024-03-14 | ATEC | Alphatec Holdings, Inc. | Bakst Evan | Dir | P - Purchase | $13.53 | +15,000 | 1,104,038 | +1% | +$202,950 | ||||||
D | 2024-03-13 | NVNO | Envveno Medical Corp | Alavi Hamed | CTO | S - Sale+OE | $6.22 | -8,334 | 0 | -100% | -$51,837 | |||||
2024-03-13 | MDXG | Mimedx Group, Inc. | Hulse William Frank IV | GC, CAO | S - Sale | $7.95 | -20,381 | 479,959 | -4% | -$162,029 | ||||||
M | 2023-03-13 | UFPT | Ufp Technologies Inc | Cardin Steve | VP | S - Sale | $197.49 | -915 | 5,039 | -15% | -$180,704 | |||||
2024-03-15 | ICUI | Icu Medical Inc/de | Woolson Daniel | VP, GM-Infusion Capital | S - Sale | $98.27 | -791 | 13,980 | -5% | -$77,733 | ||||||
2024-03-14 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.00 | -3,994 | 42,583 | -9% | -$79,880 | ||||||
2024-03-14 | BDX | Becton Dickinson & Co | Spoerel Thomas J | SVP,Controller, Chief Acct Off | S - Sale | $238.29 | -282 | 2,393 | -11% | -$67,198 | ||||||
2024-03-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.22 | +5,000 | 15,204,290 | 0% | +$6,096 | ||||||
DM | 2024-03-13 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $1.99 | -42,555 | 618,750 | -6% | -$84,882 | |||||
D | 2024-03-13 | CERS | Cerus Corp | Moore Carol | SVP Reg., Quality | S - Sale+OE | $2.02 | -20,619 | 490,623 | -4% | -$41,553 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale+OE | $2.02 | -35,284 | 490,912 | -7% | -$71,107 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $2.02 | -53,041 | 878,653 | -6% | -$106,892 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale+OE | $2.04 | -125,926 | 3,181,281 | -4% | -$256,377 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Corash Laurence M | Chief Scientific Officer | S - Sale+OE | $2.02 | -28,427 | 2,339,740 | -1% | -$57,288 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $2.02 | -35,115 | 459,612 | -7% | -$70,766 | |||||
2024-03-12 | AORT | Artivion, Inc. | Getz Matthew A | VP, HR | S - Sale | $19.94 | -5,000 | 43,536 | -10% | -$99,720 | ||||||
A | 2024-02-26 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $20.27 | -2,134 | 137,888 | -2% | -$43,259 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,007 | 81,726 | -4% | -$60,955 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Maney Rochelle L. | VP, Quality | S - Sale | $20.27 | -2,282 | 44,518 | -5% | -$46,259 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $20.27 | -2,838 | 166,852 | -2% | -$57,529 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $20.27 | -2,367 | 44,580 | -5% | -$47,982 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $20.27 | -3,461 | 162,572 | -2% | -$70,158 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81,261 | -1% | -$9,223 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Maney Rochelle L. | VP, Quality | S - Sale | $19.83 | -370 | 44,148 | -1% | -$7,339 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $19.83 | -421 | 44,159 | -1% | -$8,350 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $19.83 | -325 | 137,563 | 0% | -$6,446 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $19.83 | -584 | 161,988 | 0% | -$11,583 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $20.27 | -30,836 | 696,253 | -4% | -$625,080 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $19.83 | -485 | 166,367 | 0% | -$9,620 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale | $18.72 | -1,152 | 139,989 | -1% | -$21,568 | |||||
A | 2024-03-01 | AORT | Artivion, Inc. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85,479 | -2% | -$28,195 | |||||
A | 2024-02-26 | AORT | Artivion, Inc. | Getz Matthew A | VP, HR | S - Sale | $20.27 | -2,280 | 46,440 | -5% | -$46,218 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Getz Matthew A | VP, HR | S - Sale | $19.83 | -325 | 46,115 | -1% | -$6,446 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Maney Rochelle L. | VP, Quality | S - Sale | $18.72 | -1,157 | 46,569 | -2% | -$21,662 | |||||
A | 2024-02-27 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $19.83 | -4,837 | 691,416 | -1% | -$95,939 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale | $18.72 | -2,380 | 169,711 | -1% | -$44,559 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Green Andrew M | VP Regulatory | S - Sale | $18.72 | -1,160 | 46,577 | -2% | -$21,718 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Getz Matthew A | VP, HR | S - Sale | $18.72 | -1,157 | 48,536 | -2% | -$21,661 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale | $18.72 | -2,022 | 165,690 | -1% | -$37,856 | |||||
A | 2024-03-05 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $18.72 | -13,996 | 706,038 | -2% | -$262,037 | |||||
2024-03-14 | ICUI | Icu Medical Inc/de | Lopez George A | Dir | S - Sale | $101.87 | -7,978 | 1,195,096 | -1% | -$812,741 | ||||||
2024-03-13 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $16.82 | -3,330 | 255,760 | -1% | -$56,023 | ||||||
2024-03-13 | SIBN | Si-Bone, Inc. | Nishimura Mika | Dir | S - Sale | $16.22 | -2,500 | 19,350 | -11% | -$40,550 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Sylvain Jereme M | EVP CFO | S - Sale | $134.41 | -11,661 | 85,534 | -12% | -$1,567,363 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Stern Sadie | EVP Chief HR | S - Sale | $133.61 | -20,321 | 80,441 | -20% | -$2,715,006 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Sayer Kevin R | Pres CEO, COB | S - Sale | $133.36 | -81,007 | 333,526 | -20% | -$10,802,803 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Leach Jacob Steven | EVP COO | S - Sale | $134.41 | -14,639 | 313,473 | -4% | -$1,967,638 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Lawver Teri L | EVP Chief Commercial Officer | S - Sale | $134.41 | -4,764 | 66,641 | -7% | -$640,333 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Dolan Matthew Vincent | EVP Strategy, Corporate | S - Sale | $134.41 | -6,710 | 48,570 | -12% | -$901,896 | ||||||
2024-03-12 | DXCM | Dexcom Inc | Brown Michael Jon | EVP GC | S - Sale | $134.41 | -8,799 | 71,306 | -11% | -$1,182,680 | ||||||
D | 2024-03-12 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale+OE | $41.91 | -6,000 | 184,961 | -3% | -$251,461 | |||||
2024-03-12 | NEPH | Nephros Inc | Amron Arthur H | Dir | P - Purchase | $2.45 | +7,000 | 98,463 | +8% | +$17,130 | ||||||
A | 2024-03-12 | ICUI | Icu Medical Inc/de | Lopez George A | Dir | S - Sale | $101.51 | -1,522 | 885,321 | 0% | -$154,497 | |||||
2024-03-12 | ATRC | Atricure, Inc. | Noznesky Justin J | Chief Mktg, Strategy Officer | S - Sale | $36.72 | -1,500 | 74,284 | -2% | -$55,080 | ||||||
D | 2024-03-11 | INSP | Inspire Medical Systems, Inc. | Griffin Jerry C | Dir | S - Sale+OE | $198.05 | -554 | 9,744 | -5% | -$109,720 | |||||
D | 2024-03-12 | MMSI | Merit Medical Systems Inc | Parra Raul Jr. | CFO, Treasurer | S - Sale+OE | $73.95 | -6,480 | 14,777 | -30% | -$479,182 | |||||
M | 2024-03-11 | ICUI | Icu Medical Inc/de | Lopez George A | Dir | S - Sale | $103.01 | -3,412 | 1,203,074 | 0% | -$351,465 | |||||
2024-03-08 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $2.40 | -29,378 | 478,061 | -6% | -$70,457 | ||||||
2024-03-08 | LMAT | Lemaitre Vascular Inc | Kamke Trent G | Senior V. P., Operations | S - Sale | $68.18 | -4,542 | 4,561 | -50% | -$309,684 | ||||||
M | 2024-03-08 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.20 | +2,235 | 15,199,290 | 0% | +$2,682 | |||||
D | 2024-03-11 | WST | West Pharmaceutical Services Inc | Winters Chad | VP, Chief Accounting Officer | S - Sale+OE | $358.82 | -815 | 1,309 | -38% | -$292,436 | |||||
2024-03-11 | KIDS | Orthopediatrics Corp | Bailey David R | Pres, CEO | S - Sale | $27.59 | -3,213 | 139,384 | -2% | -$88,647 | ||||||
2024-03-11 | KIDS | Orthopediatrics Corp | Gerritzen Daniel J | GC, Secretary | S - Sale | $27.59 | -2,741 | 52,403 | -5% | -$75,624 | ||||||
2024-03-11 | KIDS | Orthopediatrics Corp | Odle Gregory A | Pres of Scoliosis | S - Sale | $27.59 | -2,768 | 80,473 | -3% | -$76,369 | ||||||
2024-03-11 | KIDS | Orthopediatrics Corp | Throdahl Mark C | Dir | S - Sale | $27.59 | -2,433 | 137,857 | -2% | -$67,126 | ||||||
2024-03-11 | KIDS | Orthopediatrics Corp | Hite Fred | COO, CFO | S - Sale | $27.59 | -3,195 | 94,072 | -3% | -$88,150 | ||||||
D | 2024-03-07 | SYK | Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | S - Sale+OE | $358.48 | -7,690 | 4,711 | -62% | -$2,756,730 | |||||
D | 2024-03-08 | ICUI | Icu Medical Inc/de | Sanzone Virginia Ruth | VP, GC | S - Sale+OE | $104.57 | -3,300 | 5,798 | -36% | -$345,088 | |||||
M | 2024-03-04 | ICUI | Icu Medical Inc/de | Lopez George A | Dir | S - Sale | $106.01 | -41,377 | 1,206,486 | -3% | -$4,386,155 | |||||
2024-03-07 | ATEC | Alphatec Holdings, Inc. | Blackford Quentin S. | Dir | P - Purchase | $12.83 | +20,000 | 572,605 | +4% | +$256,600 | ||||||
2024-03-06 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $13.16 | -9,225 | 295,870 | -3% | -$121,401 | ||||||
DM | 2024-03-06 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $86.43 | -13,347 | 30,620 | -30% | -$1,153,557 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |